期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
功能性高危骨髓瘤患者的临床特征及预后分析
1
作者 余婕 赵薇薇 +7 位作者 刘瑶 高新宇 常玉莹 韩碧清 薛艳明 董秀帅 潘珍珍 王巍 《哈尔滨医科大学学报》 CAS 2024年第3期237-243,共7页
目的分析功能性高危骨髓瘤(functional high-risk myeloma,FHR)患者的临床特征及影响预后的因素。方法纳入2017年1月~2022年5月在哈尔滨医科大学附属第二医院血液科收治的53例从诊断至出现复发和诱导欠佳的多发性骨髓瘤(multiple myelom... 目的分析功能性高危骨髓瘤(functional high-risk myeloma,FHR)患者的临床特征及影响预后的因素。方法纳入2017年1月~2022年5月在哈尔滨医科大学附属第二医院血液科收治的53例从诊断至出现复发和诱导欠佳的多发性骨髓瘤(multiple myeloma,MM)患者,根据复发时间,将≤12个月出现复发的24例MM患者归为FHR组,>12个月出现复发的29例患者归为对照组。统计分析2组患者的性别、年龄和临床资料,用Logistic回归模型逐步法筛选危险因素,筛选出有意义的临床指标并采用多因素分析探讨早期复发的高危因素。此外,将初诊时具有高危细胞遗传学异常(high-risk cytogenetic abnormality,HRCA)的患者归为基因高危组(genome high risk group,GHR组),其余未具有HRCA的患者根据疾病复发时间再分组,分为修订-功能性高危(revised-functional high risk group,R-FHR组)(≤12个月)和标准风险(standard risk group,SR组)(>12个月),采用Kaplan-Meier法绘制生存曲线,分析复发时间对总体生存率(overall survival,OS)的影响。结果(1)与对照组比较,FHR组患者合并髓外病变(extramedullary disease,EMD)的发生率更高(16.67%vs 0.00%,P=0.022);初诊时具有HRCA比例显著高于对照组(41.67%vs 13.79%,P=0.022);FHR组患者与对照组经一线治疗后≥非常好的部分缓解(very good partial response,VGPR)率、总缓解率(overall response rate,ORR)分别为20.83%vs 82.76%、87.5%vs 100%,前者疗效较差,≥VGPR率两组间比较差异具有统计学意义(P<0.001)。(2)所有患者的中位随访时间32.08(23.87~44.03)个月。FHR组患者与对照组患者中位OS分别为24.0个月vs 65.8个月(P<0.05)。(3)在53例MM患者中,GHR组患者14例,R-FHR组患者14例,SR组患者25例,经生存性分析显示,SR、R-FHR和GHR 3组的中位OS分别为65.8个月、23.0个月和32.0个月(P<0.05)。结论FHR患者对初始治疗反应差,合并髓外病变比例高,即使排除任何高危细胞遗传学因素,总体生存时间仍明显缩短,需要临床医生高度关注。 展开更多
关键词 功能性高危骨髓 疾病进展 危险因素 总生存期
原文传递
盆腔肿瘤IMRT下骨髓剂量-体积参数与急性血液学毒性相关性研究进展 被引量:3
2
作者 陈宏博 余增荣 +1 位作者 丁小凡(综述) 肖林(审校) 《实用肿瘤学杂志》 CAS 2019年第4期361-366,共6页
盆腔恶性肿瘤同期放化疗期间发生骨髓抑制的风险较高,盆腔受照射骨髓(骼)的剂量-体积关系与放化疗期间的急性血液学毒性存在相关,但缺乏此方面公认的参数。盆腔不同部位骨髓(骼)造血能力具有异质性,靠近体中轴的盆腔骨髓造血能力最强,... 盆腔恶性肿瘤同期放化疗期间发生骨髓抑制的风险较高,盆腔受照射骨髓(骼)的剂量-体积关系与放化疗期间的急性血液学毒性存在相关,但缺乏此方面公认的参数。盆腔不同部位骨髓(骼)造血能力具有异质性,靠近体中轴的盆腔骨髓造血能力最强,即功能性骨髓。找准盆腔功能性骨髓的剂量-体积参数与盆腔恶性肿瘤放化疗期间急性血液学毒性的关系也许是今后发展方向。 展开更多
关键词 盆腔恶性肿瘤 放射治疗 骨髓抑制 功能性骨髓 剂量-体积
下载PDF
Clinical Features of Renal Insufficiency due to Multiple Myeloma and Related Risk Factors 被引量:1
3
作者 刘雪梅 徐金兰 +1 位作者 官旭华 刘丽秋 《The Chinese-German Journal of Clinical Oncology》 CAS 2005年第1期47-49,68,共4页
Objective: To study clinical features of the patients with multiple myeloma(MM) accompanied by renal insufficiency and investigate the related risk factors of renalimpairment. Methods: A control study of clinical char... Objective: To study clinical features of the patients with multiple myeloma(MM) accompanied by renal insufficiency and investigate the related risk factors of renalimpairment. Methods: A control study of clinical characteristics was performed between 91 patientswith renal insufficiency due to MM and 165 patients with normal renal function in MM during the sameperiod. The data were statistically analyzed by chi-square test and logistic regression analysis.Results: Renal insufficiency was the initial presentation in 48 (52.7%) of the 91 patients, and 30(62.5%) of the 48 patients were misdiagnosed. The prognosis of group with renal insufficiency wassignificantly poorer than that of group with normal renal function: mortality in 3 months, 3months-1 year was 26/91 vs 14/165 (P 【 0.0001), 14/91 vs 12/165 (P 【 0.05) respectively, andpatients survived 】 1 year was 18/91 vs 95/165 (P 【 0.0001). The incidence of hypercalcemia,hyperuricemic, severe anemia, high serum M-protein concentration and lytic bone lesions weresignificantly higher in renal insufficiency group than those in control group (P 【 0.05). Logisticregression analysis identified 5 risk factors of renal impairment, including, severe anemia(Exp(β)=13.819, P 【 0.0001), use of nephrotoxic drugs (Exp(β)=6.217, P = 0.001), high serumM-protein concentration (Exp(β) = 5.026, P = 0.001), male (Exp(β)=3.745, P=0.006), andhypercalcemia (Exp(β)=3A72, P=0.006), but age, serum density of uric acid, type of serum M-protein,and Bence Jones proteinuria were not significantly associated with renal insufficiency. Conclusion:Renal insufficiency was a common early complication of MM, which often resulted in misdiagnosis.The status of these patients tended to be very bad, with many other complications, when MM wasdiagnosed, so their prognosis was poor. The occurrence of renal insufficiency in patients with MMand hypercalcemia, severe anemia, high serum M-protein concentration, especially use of nephrotoxicdrugs should be alert. 展开更多
关键词 multiple myeloma renal insufficiency clinical feature risk factor
下载PDF
Hepatic failure caused by plasma cell infiltration in multiple myeloma 被引量:2
4
作者 Fadi E Rahhal Robert R Schade +1 位作者 Asha Nayak Teresa A Coleman 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第16期2038-2040,共3页
Although plasma cell infiltration is not rare in autopsy of patients with multiple myeloma (MM), it is very rarely detected in living patients. This is because MM rarely causes significant liver dysfunction that req... Although plasma cell infiltration is not rare in autopsy of patients with multiple myeloma (MM), it is very rarely detected in living patients. This is because MM rarely causes significant liver dysfunction that requires further evaluation. A 49-year-old man presented with acute renal failure and was diagnosed with kappa light chain MM stageⅡB. Thalidomide and dexamethasone were initiated. The patient developed a continuous increase in bilirubin that led to severe cholestasis. A liver biopsy revealed plasma cell infiltration. He then rapidly progressed to liver failure and died. Treatment options are limited in MM with significant liver dysfunction. Despite new drug therapies in MM, those patients with rapidly progressive liver failure appear to have a dismal outcome. 展开更多
关键词 Hepatic failure Multiple myeloma Cell infiltration
下载PDF
Renal impairment in multiple myelomas
5
作者 Cheng Yang Tianbiao Lan Yi Cheng 《The Chinese-German Journal of Clinical Oncology》 CAS 2011年第7期418-422,共5页
Objective: The aim of the study was to investigate the clinic manifestation, diagnosis and treatment on multiple myeloma (MM) with the onset of renal impairment. Methods: The 27 cases of multiple myeloma with the onse... Objective: The aim of the study was to investigate the clinic manifestation, diagnosis and treatment on multiple myeloma (MM) with the onset of renal impairment. Methods: The 27 cases of multiple myeloma with the onset of renal impair-ment were collected in Department of Nephrology, Wuhan General Hospital of Guangzhou Command, China, from January 2007 to January 2011. All cases were divided into the groups with renal dysfunction (n = 16) and normal renal function (n = 11). The clinic manifestations, treatments and prognosis of all patients were analyzed. Results: Of all the patients in normal renal function group, 5 suffered nephrotic syndrome, 4 had abnormal results of routine urinalysis (hematuria or proteinuria) which were not caused by nephrotic syndrome, and 1 suffered urinary tract infection. Five pathological specimens of renal biopsy revealed that light chain protein, immunoglobulin and complement C3 were deposited mainly in the glomerular base-ment membrane and mesangia, tubular basement membrane and arteriolar walls. Two pathological specimens were proved to be renal amyloidosis. Patients with renal dysfunction had poorer prognosis, severer anemia, higher values of serum lactate dehydrogenase (LDH) and β2-microglobulin (β2-MG), worse responses to chemotherapy. Of 16 patients with renal dysfunc-tion, 14 (87.5%) were stage III, which were significantly higher than that in the group of normal renal function [63.6% (7/11)]. Of 16 cases with renal dysfunction, 9 were treated with blood purification, and 5 of 9 cases were treated with plasma exchange. Conclusion: Multiple myeloma with the onset of renal impairment was easily misdiagnosed. Hemodialysis concomitant with chemotherapy could contribute to recovery of renal function. 展开更多
关键词 multiple myeloma (MM) renal impairment DIAGNOSIS TREATMENT
下载PDF
Effects of Epstein-Barr virus infection on the development of multiple myeloma after liver transplantation 被引量:2
6
作者 ZHANG YeWei ZHAO HeWei +7 位作者 HE Xia ZHENG SuWen WANG TaiHong YAN DongLiang SUN JingFeng LU Xiang WEN JianFei LAU Wan Yee 《Science China(Life Sciences)》 SCIE CAS 2012年第8期735-743,共9页
Reduced cellular immune function in patients after liver transplantation easily results in many types of viral infections,such as Epstein-Barr virus.Epstein-Barr virus is a γ-herpesvirus and is related to many malign... Reduced cellular immune function in patients after liver transplantation easily results in many types of viral infections,such as Epstein-Barr virus.Epstein-Barr virus is a γ-herpesvirus and is related to many malignant diseases,especially epithelial and lymph tumors.The abnormal interaction of cluster of differentiation 40 with cluster of differentiation 40 ligand and expression of cluster of differentiation 40 ligand are considered closely related to the development of myeloma cells.This study explored the influence and mechanism of Epstein-Barr virus infection on the phenotype and biological behavior of myeloma cells after liver transplantation.Flow cytometry was used to detect coexpression of cluster of differentiation 40 and cluster of differentiation 40 ligand in 10 samples of freshly isolated multiple myeloma cells.Cluster of differentiation 40 and cluster of differentiation 40 ligand were coexpressed in sample Nos.5,8,9,and 10,particularly in sample No.5.Western blot analysis was used to detect the expression of the Epstein-Barr virus antigens latent membrane protein 1 and Epstein-Barr virus nuclear antigen 2 in the multiple myeloma cell line RPMI 8226 infected with Epstein-Barr virus.The antigen expression indicated that Epstein-Barr virus can infect multiple myeloma virus cells in vitro.Reverse transcription-polymerase chain reaction revealed upregulated expression of cluster of differentiation 40 ligand on the infected RPMI 8226 cells,which may be involved in the anti-apoptosis activity of the infected cells.Confocal microscopy showed that pairs of molecules of cluster of differentiation 40,cluster of differentiation 40 ligand,and latent membrane protein 1 were colocalized on the surface of the infected cells.CXC chemokine receptor 4 was upregulated on the RPMI 8226 cells after Epstein-Barr virus infection.The migratory ability of the infected cells improved in the presence of the chemokine stromal cell-derived factor-1α.Anti-apoptosis and migration are known important biological characteristics of malignant cells.Our results indicate the involvement of Epstein-Barr virus in the origin and development of multiple myeloma.The risk of multiple myeloma increases when Epstein-Barr virus infects B cells in the germinal center,which may result in an anti-apoptosis effect of B cells and an improved ability to migrate from the germinal center to peripheral blood. 展开更多
关键词 liver transplantation CD40 CD40L multiple myeloma EBV
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部